Study Title: A Single Arm Phase I/II Study of Tazemetostat with Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma
 

• Open to Accrual at:
  • University of Illinois Cancer Center
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University
  • The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
  • Rutgers Cancer Institute of New Jersey
  • University of Wisconsin Carbone Cancer Center
• Learn more:
  • https://www.clinicaltrials.gov/study/NCT05551936
• Publications and Presentations: 
  • Poster Presentation: 2024 American Society of Hematology Annual Meeting

Study Contact: studies@hoosiercancer.org; (317) 921-2050.